Download Files:
285 CAD – 3,392 CADPrice range: 285 CAD through 3,392 CAD
Products Details
Product Description
– Rovalpituzumab is a humanized monoclonal antibody targeting delta-like protein 3 (DLL3) and is utilized to synthesize antibody-active molecule conjugates (ADCs). It exhibits anticancer activity and is used in the treatment of small cell lung cancer (SCLC).
Web ID
– T76698
Storage Temperature
– -20℃
Shipping
– Blue Ice
References
– Bilal H Lashari, et al. Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody-Drug Conjugate. Drugs R D. 2018 Dec;18(4):255-258.
CAS Number
– 1613313-01-1
Molecular Weight
Compound Purity
– > 95%
Pathway
– Proteases/Proteasome|||Neuroscience|||Stem Cells
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
1000 in stock
1000 in stock